COMPANION DIAGNOSIS CDx COOPERATION
Expert drug target consultation | IVD product development & global registration application
GLOBAL CDx
DEVELOPMENT &
REGISTRATION
Genetron Health offers extensive experience in the registration of instruments and IVD kits, and can provide pharmaceutical partners with personalized and integrated companion diagnostic kit development services. After the introduction of the guidance for companion diagnostic reagent, Genetron Health has developed the first bridging companion diagnostic kit approved by NMPA.
OUR APPROVEDCUSTOM DEVELOPMENT
- Gene editing therapy
- In-vitro cell editing efficiency
Effect monitoring
CO-DEVELOPMENT
- Small molecule targeted drug
clinical trial detection & CDx
Same phase co-development
Co-Testing NGS CDx
- Targeted Drugs for Solid Tumors
- Targeted Drugs for Fusion Genes
- Applicable for Testing and Companion Diagnostics